August 05, 2026
Foreign Influence Transparency Commissioner Anton Boegman has issued guidance about when “licensed legal professionals” are required to register their work for foreign principals as “influence activities” in the new public foreign influence registry. The new commissioner issued five interpretation bulletins — including one specifically for lawyers — to give guidance on how to comply with the obligations under the Foreign Influence Transparency and Accountability Act (FITAA) and its regulations, which came into force Aug. 4.
July 31, 2026
Tristan Tremblay has joined Langlois’ litigation group in Quebec City.
July 31, 2026
Artificial intelligence is reshaping economies, industries and the global competitive landscape at an unprecedented pace. Recognizing both the opportunities and the risks presented by this technological shift, the federal government launched Canada’s National Artificial Intelligence Strategy: AI for All on June 4, 2026.
July 30, 2026
In an administrative law landmark that addresses the scope of the Constitution’s guarantee of judicial review, the Supreme Court of Canada has ruled 9-0 that legislatures cannot validly use privative clauses to bar “legality review” by courts — i.e., the availability of curial review is constitutionally guaranteed for all aspects of delegated administrative decisions, including on questions of law, fact or mixed law and fact.
July 29, 2026
As artificial intelligence grows more capable, human skills are becoming more valuable, not less. For decades, the legal profession around the world has rewarded expertise built on deep research, careful analysis and meticulous attention to detail. Today, AI can perform many of those tasks in seconds, summarizing thousands of documents, identifying relevant case law, drafting contracts, analyzing litigation trends and even suggesting legal arguments.
July 29, 2026
Health Canada has been granted a permanent injunction against Canlab Research and its representatives that prevents the company from selling unauthorized injectable peptides in Canada.
July 24, 2026
Gowling WLG has welcomed Guillaume Lavoie Ste-Marie as a partner in its intellectual property litigation and strategy group in Montreal.
July 24, 2026
On July 23, the federal government launched a public consultation “seeking views on how to strengthen transparency for AI systems and AI-generated outputs.”
July 23, 2026
The 21st century has witnessed the emergence of a new form of commons, one that exists not on open pastures, in forests or upon the high seas, but within the vast and interconnected architecture of the digital world. Information, data, online platforms, open source software, digital knowledge repositories and artificial intelligence training materials have collectively given rise to what scholars increasingly describe as the digital commons.
July 17, 2026
The Supreme Court of Canada has reaffirmed that Canadian patent law bars patent claims for “methods of medical treatment” but has also clarified that drug-dosing regimens can be patentable subject matter if they do not seek to monopolize professional medical skill and judgment. In its 158-page judgment handed down July 17, the top court 9-0 dismissed the appeal by generic drug manufacturer Pharmascience Inc. from decisions of the Federal Court and Federal Court of Appeal that affirmed the validity of the patent owned by the respondents, Janssen Inc. and Janssen Pharmaceutica N.V.